Spatiotemporal analysis of ROS in hepatic ischemia-reperfusion and prediction of organ damage using MRI

Atsushi Yamashita1,2, Hitoshi Togashi3, Kazuyuki Haga4

  • 1Division of Cardiovascular Surgery, Second Department of Surgery, Faculty of Medicine, Yamagata University, Japan.

Free Radical Research
|October 9, 2025
PubMed

Insights

This study monitored reactive oxygen species (ROS) in a rat model of liver injury using advanced MRI. Early detection and intervention with edaravone significantly reduced liver damage, showing potential for clinical application.

Area of Science:

  • Biomedical Imaging
  • Hepatology
  • Oxidative Stress Research

Background:

  • Hepatic ischemia-reperfusion injury is a significant clinical challenge.
  • Reactive oxygen species (ROS) play a critical role in the pathogenesis of this injury.
  • Current methods for monitoring ROS in vivo are limited.

Purpose of the Study:

  • To investigate the spatiotemporal dynamics of ROS during hepatic ischemia-reperfusion injury.
  • To evaluate the potential of a novel MRI-based imaging probe for ROS detection.
  • To assess the therapeutic efficacy of early intervention targeting ROS.

Main Methods:

  • A rat model of partial hepatic ischemia-reperfusion was established.
  • 1-acetoxy-3-carbamoyl-2,2,5,5-tetramethylpyrroline (ACP), an imaging probe, was used with MRI to detect ROS.
  • Edaravone was administered to target excessive ROS production post-reperfusion.

Main Results:

  • Significant ROS generation was detected in the ischemic liver region using ACP-enhanced MRI.
  • Early hepatocellular necrosis was observed 12 hours after reperfusion.
  • Edaravone administration at 1 hour post-reperfusion significantly attenuated liver injury.

Conclusions:

  • ACP-enhanced MRI is a viable tool for spatiotemporal ROS monitoring in hepatic ischemia-reperfusion.
  • Targeting ROS production early after reperfusion can mitigate liver injury.
  • This approach holds promise for early clinical intervention in organ damage.